Search Within

Solid Tumor Oncology Division

  1. "Neuro-Oncology"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (12)
Groups
  1. Department of Medicine (65)
  2. GSK Faculty (31)
  3. Thoracic Oncology (27)
  4. Tow Center for Developmental Oncology (TCDO) (20)
  5. Breast Medicine Service (17)
  6. Human Oncology and Pathogenesis Program (16)

More Groups

People
  1. Alexander Drilon (12)
  2. Andrew Seidman (8)
  3. Elena Pentsova (7)
  4. Adrienne Boire (6)
  5. Bianca Santomasso (6)
  6. Igor Gavrilovic (6)

More People

Years
  1. 2024 (7)
  2. 2023 (9)
  3. 2022 (8)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Neuro-Oncology (65)
Publishers
  1. Oxford University Press (65)

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and brain metastases (BM) in the ASCEND-1 trial
    Meeting Abstract

    Shaw, A.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • JAK 1/2 inhibition following bone marrow transplantation mitigates Cd11b + /GR1+ mediated low-grade glioma neoangiogenesis
    Meeting Abstract

    Rajappa, P.; Huang, Y. J.; Vartanian, E.; Pisapia, D.; Lyden, D.; Bromberg, J.; Greenfield, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Prognostic importance of health-related quality of life and fatigue in newly diagnosed glioblastoma
    Meeting Abstract

    Peters, K.; Randazzo, D.; Affronti, M.; Lipp, E.; McSherry, F.; Herndon, J.; Flahiff, C.; Miller, E.; Woodring, S.; Freeman, M.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • ID2/KDR drives formation of pro-malignant myeloid derived suppressor cells in glioma
    Meeting Abstract

    Huang, Y. J.; Rajappa, P.; Bromberg, J.; Lyden, D.; Greenfield, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Mebendazole is efficacious in diverse medulloblastoma tumor models and inhibits tumor angiogenesis
    Meeting Abstract

    Bai, R. Y.; Staedtke, V.; Rudin, C.; Bunz, F.; Riggins, G.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients with brain metastases from breast cancer
    Journal Article

    Peereboom, D. M.; Murphy, C.; Ahluwalia, M. S.; Conlin, A.; Eichler, A.; Van Poznak, C.; Baar, J.; Elson, P.; Seidman, A. D.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Anaplastic lymphoma kinase (ALK) positive central nervous system (CNS) metastases from non small cell lung cancer (NSCLC)
    Meeting Abstract

    Singer, S.; Riely, G. J.; Kris, M. G.; Grommes, C.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
    Meeting Abstract

    Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Jak-1/2 inhibition impairs bone marrow-derived cell recruitment, preventing low-grade to high-grade glioma transformation
    Meeting Abstract

    Rajappa, P.; Cobb, W. S.; Huang, Y. J.; Lyden, D. C.; Bromberg, J.; Greenfield, J. P.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Capecitabine entry into brain metastases in women with breast cancer
    Meeting Abstract

    Peereboom, D. M.; Seidman, A. D.; Tabar, V.; Weil, R. J.; Thorsheim, H. R.; Smith, Q. R.; Lockman, P. R.; Steeg, P. S.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save